Professor of Urology, the Warschaw, Robertson, Law Families Chair in Prostate Cancer, and the Associate Director of Cedars-Sinai Cancer at Cedars-Sinai. He is focuses on prostate cancer with interests in lifestyle, health disparities, and risk stratification. He was co-PI of the global phase 3 EMBARK study. He sits on the editorial board for multiple journals including Nature Reviews Urology and is editor-emeritus for Prostate Cancer and Prostatic Diseases. He earned his MD from UC Davis, completed urology residency at UCLA and a urological oncology fellowship at Johns Hopkins.